Insider · CIK 0001798443

Kalif Eliyahu Sharon

Reports to the SEC for 1 company · TEL AVIV

sec.gov

Transactions

Companies

Filings

CIK

0001798443

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-11	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Chief Financial Officer	SSale	−107K sh	$34.10	−$3.63M	65,621
2026-05-14	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Chief Financial Officer	SSale	−153K sh	$35.61	−$5.46M	172,184
2026-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+19.9K sh	—	—	325,435
2026-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−19.9K sh	—	—	59,748
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+33.5K sh	—	—	282,268
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+23.3K sh	—	—	305,519
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−33.5K sh	—	—	0
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−23.3K sh	—	—	46,503
2026-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Chief Financial Officer	AAward	+53.2K sh	—	—	53,175
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+49.8K sh	—	—	107,278
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+141K sh	—	—	248,756
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−49.8K sh	—	—	49,802
2026-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−141K sh	—	—	0
2026-02-26	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Chief Financial Officer	SSale	−346K sh	$33.64	−$11.6M	57,478
2026-01-27	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Chief Financial Officer	AAward	+141K sh	—	—	141,478
2025-06-12	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Chief Financial Officer	SSale	−55.8K sh	$17.08	−$952K	403,288
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+21.4K sh	—	—	459,063
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−21.4K sh	—	—	0
2025-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Chief Financial Officer	AAward	+79.7K sh	—	—	79,664
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+33.5K sh	—	—	231,253
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+23.3K sh	—	—	254,504
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+183K sh	—	—	437,673
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−33.5K sh	—	—	33,512
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−23.3K sh	—	—	69,754
2025-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−183K sh	—	—	0
2025-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+49.8K sh	—	—	197,741
2025-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−49.8K sh	—	—	99,602
2025-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Chief Financial Officer	SSale	−55.8K sh	$16.21	−$903K	147,941
2025-01-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Chief Financial Officer	AAward	+183K sh	—	—	183,169
2024-03-06	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Chief Financial Officer	SSale	−77.6K sh	$13.52	−$1.05M	203,691
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+52.3K sh	—	—	259,854
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+21.4K sh	—	—	281,241
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−21.4K sh	—	—	21,390
2024-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−52.3K sh	—	—	0
2024-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+33.5K sh	—	—	207,534
2024-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−33.5K sh	—	—	207,534
2024-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Chief Financial Officer	AAward	+93K sh	—	—	93,005
2024-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+49.8K sh	—	—	174,022
2024-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−49.8K sh	—	—	174,022
2024-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+18.4K sh	—	—	124,222
2024-02-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−18.4K sh	—	—	0
2024-02-13	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+6,630 sh	—	—	105,792
2024-02-13	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−6,630 sh	—	—	0
2024-01-30	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Chief Financial Officer	AAward	+52.3K sh	—	—	52,320
2023-08-07	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDS Sale	EVP, Chief Financial Officer	SSale	−35.1K sh	$9.73	−$342K	99,162
2023-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+21.4K sh	—	—	134,287
2023-03-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−21.4K sh	—	—	42,777
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	+33.5K sh	—	—	112,900
2023-03-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	EVP, Chief Financial Officer	MExercise/Conversion	−33.5K sh	—	—	100,536
2023-03-03	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	EVP, Chief Financial Officer	AAward	+199K sh	—	—	199,202

Recent filings

Accepted (ET)
Jun 164
Kalif Eliyahu Sharon0001193125-26-271862
SEC(opens sec.gov)
May 184
Kalif Eliyahu Sharon0001193125-26-228870
SEC(opens sec.gov)
Mar 94
Kalif Eliyahu Sharon0001193125-26-098573
SEC(opens sec.gov)
Mar 64
Kalif Eliyahu Sharon0001193125-26-096513
SEC(opens sec.gov)
Mar 54
Kalif Eliyahu Sharon0001193125-26-093903
SEC(opens sec.gov)
Mar 24
Kalif Eliyahu Sharon0001193125-26-085343
SEC(opens sec.gov)
Jan 294
Kalif Eliyahu Sharon0001193125-26-029337
SEC(opens sec.gov)
Jun 164
Kalif Eliyahu Sharon0000950170-25-086697
SEC(opens sec.gov)
Mar 74
Kalif Eliyahu Sharon0000950170-25-035528
SEC(opens sec.gov)
Mar 64
Kalif Eliyahu Sharon0000950170-25-034651
SEC(opens sec.gov)

Companies

TEVA PHARMACEUTICAL INDUSTRIES LTDEVP, Chief Financial OfficerTEVA

Address

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST.,

TEL AVIV, 6944020